Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Università Campus Bio-Medico di Roma, Rome

Liverpool Hospital, Liverpool

Newcastle Private Hospital, Newcastle

Antwerp University Hospital, Edegem

Austin Health, Heidelberg

Flinders Medical Centre, Bedford Park

Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia, Perugia

Yale University, New Haven

Memorial Sloan Kettering Cancer Center, New York

Taipei Veterans General Hospital, Taipei

North Shore Hem Onc Associates, East Setauket

Evang. Lungenklinik Berlin Klinik für Pneumologie, Berlin

Hôpital de la Timone, Marseille

Hôpital Nord - AP-HM Marseille#, Marseille

Georgetown University Medical Center Lombardi Cancer Center, Washington D.C.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda), Milan

Weinberg Cancer Institution at Franklin Square, Baltimore

Virginia Cancer Specialists, PC, Fairfax

Virginia Oncology Associates - Hampton, Norfolk

Duke Cancer Institute, Durham

Hospital Universitario Ramon y Cajal, Madrid

Hospital Universitario Clínico San Carlos, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario La Paz, Madrid

Levine Cancer Institute, Charlotte

Centro Nacional de Investigaciones Oncológicas(CNIO), Fuenlabrada

Hospital Clinico Universitario Virgen de la Victoria, Málaga

Southeastern Regional Medical Center, Inc., Newnan

Winship Cancer Institute, Atlanta

University Cancer & Blood Center, LLC, Athens

Institut Claudius Regaud, Toulouse

Institut Bergonie, Bordeaux

Institut de Recherche en Cancérologie de Montpellier, Montpellier

Florida Cancer Specialists - Sarasota, Sarasota

IOV - Istituto Oncologico Veneto - IRCCS, Padua

Universitaetsmedizin Goettingen, Göttingen

Hospital Universitario Virgen del Rocio, Seville

Ohio State University, Columbus

OSU, James Cancer Hospital, Columbus

Institut De Cancerologie De L'ouest - Rene Gauducheau - Biology, Saint-Herblain

University of Michigan Comprehensive Cancer Center, Ann Arbor

Karmanos Cancer Center, Detroit

Henry Ford Hospital, Detroit

Institut de Cancerologie de l Ouest, Angers

Universitaetsklinikum Koeln, Cologne

Regents of the University of Minnesota, Minneapolis

Azienda Ospedaliero Universitaria Pisana, Pisa

Advocate Medical Group - Park Ridge, Luther Lane - Oncology, Park Ridge

Midwestern Regional Medical Center, Zion

Northwestern University, Chicago

Washington University, St Louis

NCT Uniklinikum Heidelberg, Heidelberg

Centre Leon Berard, Lyon

National Cheng Kung University Hospital, Tainan City

Cancer Treatment Centers of America, Tulsa

Institut Curie, Paris

Mary Crowley Medical Research Center, Dallas

Baylor Scott & White Health, Temple

University of Texas MD Anderson Cancer Center, Houston

University of Colorado Cancer Center, Aurora

Seconda Università degli Studi di Napoli, Napoli

University of Utah Hospitals & Clinics, Salt Lake City

Dignity Health St Joseph's Hospital and Medical Center, Phoenix

Mayo Clinic, Phoenix

Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley, Las Vegas

Southern California Kaiser Permanente, Los Angeles

University of Southern California Medical Center, Los Angeles

Sarcoma Oncology Center, Santa Monica

Sarcoma Oncology Research Center LLC, Santa Monica

City of Hope Cancer Center, Duarte

City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services, Duarte

Scripps Clinic, La Jolla

University of California San Diego Moores Cancer Center, La Jolla

Univ Of California Irvine College Of Medicine, Orange

UCSF Mount Zion Medical Ctr, San Francisco

UCSF Mission Bay, San Francisco

Institut Gustave Roussy, Villejuif

Oregon Health & Science Univ, Portland

University of Washington Seattle Cancer Care Alliance, Seattle

Beijing Cancer Hospital, Beijing

National University Hospital, Singapore

The Chinese University of Hong Kong, Shatin

Harbin Medical University Cancer Hospital, Harbin

National Cancer Centre, Singapore

Shanghai chest hospital, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

Zhejiang Cancer Hospital, Hangzhou

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Cancer Center of Guangzhou Medical University, Guangzhou

Shenzhen People's Hospital, Shenzhen

Sichuan Provincial Cancer Hospital, Chengdu

H. Lee Moffitt Cancer Center and Research Inst., Tampa

Massachusetts General Hosp CAR, Boston

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Oregon Health & Science University, Portland

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden

Princess Margaret Hospital, Hong Kong

The University of Hong Kong, Hong Kong

Queen Elizabeth Hospital, Kowloon

Aichi Cancer Center Hospital, Aichi

National Cancer Center Hospital, Chūō

NHO Kyushu Cancer Center, Fukuoka

Hyogo Cancer Center, Dept of Respiratory Medicine, Hyōgo

National Cancer Center Hospital, Kashiwa-shi

NHO Shikoku Cancer Center, Matsuyama

Miyagi Cancer Center, Miyagi

Niigata Cancer Center Hospital, Niigata

Osaka City General Hospital, Osaka

Kindai University Hospital, Osaka

Shizuoka Cancer Center, Shizuoka

NKI The Netherlands Cancer Institute, Amsterdam

Leids Universitair Medisch Centrum, Leiden

Uniwersyteckie Centrum Kliniczne, Gdansk

Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Gliwice

Szpital Kliniczny Przemienienia Panskiego Uni. Medycznego im. Karola Marcinkowskiego, Późna

Centrum Onkologii Instytut im. M. Sklodowskiej-Curie, Klinika Nowotworow Ukladu Chlonnego, Warsaw

Seoul National University Hospital, Seoul

Asan Medical Center., Seoul

Samsung Medical Center, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona

National Taiwan University Hospital, Taipei

Addenbrookes Hospital, Cambridge

Sarah Cannon Research Institute, London

The Christie, Manchester